Diagnostic accuracy of NT-proBNP to predict the incidence of CSA-AKI: A systematic review and meta-analysis

Jiaying Zhang,Xin Li,Xiaofeng Yu
DOI: https://doi.org/10.1097/md.0000000000039479
IF: 1.6
2024-10-30
Medicine
Abstract:Acute kidney injury (AKI) is a severe complication after cardiac surgery, which not only has a high morbidity and mortality but also brings a heavy economic burden to hospitalized patients. Every year, >2 million cardiac surgeries are conducted worldwide. [ 1 ] The morbidity of cardiac surgery–associated acute kidney injury (CSA-AKI) is 2% to 50%, [ 2 ] with a mortality ranging from 3.8% to 54.4% [ 3 ] ; around 1% to 15% of patients with CSA-AKI require renal replacement therapy. [ 4 ] The pathological and physiological mechanisms of CSA-AKI are complex, mainly including ischemia-reperfusion injury, renal hypoperfusion, inflammation, oxidative stress, neurohormonal activation, nephrotoxic exposure, raised intra-abdominal pressure, renal congestion, and cardiopulmonary bypass. [ 2 , 5 , 6 ] The Risk, Injury, Failure, Loss, and End-stage renal disease criteria, [ 7 ] Acute Kidney Injury Network criteria, [ 8 ] and Kidney Disease Improving Global Outcomes criteria [ 9 ] are the primary diagnostic criteria for CSA-AKI. These criteria are based on traditional markers of renal function, serum creatinine, and urinary output. Due to the kidneys' strong reserve capacity, structural and functional damage frequently occurs before the increase of urea nitrogen and creatinine; hence, these indicators are not ideal as sensitive biomarkers for predicting the incidence of CSA-AKI. [ 10 ] Therefore, finding a sensitive biomarker for early identification of CSA-AKI is significant.
medicine, general & internal
What problem does this paper attempt to address?